Inventor · disambiguated record
John F. Palma
Also filed as: PALMA JOHN · PALMA JOHN F
13 granted patents·16 pending applications·126 citations·filing 2002–2022
88Inventor score
Files withMETABOLEX INC8ROCHE SEQUENCING SOLUTIONS INC6AFFYMETRIX INC4JANSSEN PHARMACEUTICA NV2UNIV MASSACHUSETTS2
Top patents by PatentIndex Score
29 records- 0195US7374927B2Methods of analysis of degraded nucleic acid samplesAFFYMETRIX INC·Filed 2005·Granted May 20, 2008·80 cites·4 claims
- 0291US7629627B2Field effect transistor with independently biased gatesUNIV MASSACHUSETTS·Filed 2006·Granted Dec 8, 2009·24 cites·20 claims
- 0387US7053180B2Isolated islet beta-cell two-pore domain potassium channelMETABOLEX INC·Filed 2003·Granted May 30, 2006·15 cites·1 claims
- 0477US7405289B2Pancreatic islet transcription factor and uses thereofMETABOLEX INC·Filed 2003·Granted Jul 29, 2008·4 cites·16 claims
- 0576US7144985B2Methods and reagents for diagnosis and treatment of diabetesMETABOLEX INC·Filed 2002·Granted Dec 5, 2006·3 cites·10 claims
- 0669US12274711B2Method of determining Acute Myeloid Leukemia response to treatment with farnesyltransferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Apr 15, 2025·0 cites·12 claims
- 0768US2023083203A1Non-invasive test to predict response to therapy in colorectal cancer patientsROCHE SEQUENCING SOLUTIONS INC·Filed 2022·Application pending·0 cites
- 0866US2013217011A1Diagnostic biomarkers of diabetesVERIDEX LLC·Filed 2012·Application pending·0 cites
- 0965US2008318312A1Pancreatic islet transcription factor and uses thereofMETABOLEX INC·Filed 2008·Application pending·0 cites
- 1064US2011275079A1Diagnostic biomarkers of diabetesPALMA JOHN F·Filed 2008·Application pending·0 cites
- 1162US7294698B2Methods and reagents for diagnosis and treatment of diabetesMETABOLEX INC·Filed 2006·Granted Nov 13, 2007·0 cites·1 claims
- 1259US11519037B2Non-invasive test to predict response to therapy in colorectal cancer patientsROCHE SEQUENCING SOLUTIONS INC·Filed 2019·Granted Dec 6, 2022·0 cites·4 claims
- 1356US7491533B2Polynucleotides encoding an isolated β-islet cell two-pore domain potassium channelMETABOLEX INC·Filed 2006·Granted Feb 17, 2009·0 cites·5 claims
- 1456US2008014579A1Gene expression profiling in colon cancersAFFYMETRIX INC·Filed 2004·Application pending·0 cites
- 1553US11559540B2Method of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jan 24, 2023·0 cites·24 claims
- 1653US2016138103A1Diagnostic biomarkers of diabetesJANSSEN DIAGNOSTICS LLC·Filed 2015·Application pending·0 cites
- 1751US2005272052A1Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancerAFFYMETRIX INC·Filed 2004·Application pending·0 cites
- 1849US2010109050A1Field effect transistor with independently biased gatesUNIV MASSACHUSETTS·Filed 2009·Application pending·0 cites
- 1949US2008064857A1Methods and Reagents for Diagnosis and Treatment of DiabetesMETABOLEX INC·Filed 2007·Application pending·0 cites
- 2047US11821041B2Non-invasive test to predict recurrence of colorectal cancerROCHE SEQUENCING SOLUTIONS INC·Filed 2019·Granted Nov 21, 2023·0 cites·4 claims
- 2147US2004029151A1Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancerAFFYMETRIX INC·Filed 2003·Application pending·0 cites
- 2247US2005208516A1Methods and reagents for diagnosis and treatment of diabetesMETABOLEX INC·Filed 2004·Application pending·0 cites
- 2345US2021292851A1Method of monitoring effectiveness of immunotherapy of cancer patientsROCHE SEQUENCING SOLUTIONS INC·Filed 2019·Application pending·0 cites
- 2444US12071661B2Method of predicting response to therapy by assessing tumor genetic heterogeneityROCHE SEQUENCING SOLUTIONS INC·Filed 2019·Granted Aug 27, 2024·0 cites·5 claims
- 2541US2013059755A1Gene Based Prediction of PSA Recurrence for Clinically Localized Prostate Cancer PatientsJOHNSON & JOHNSON·Filed 2012·Application pending·0 cites
- 2638US2011009288A1Methods and reagents for the early detection of melanomaTALANTOV DMITRI·Filed 2010·Application pending·0 cites
- 2735US2017349953A1Novel mutations in anaplastic lymphoma kinase predicting response to alk inhibitor therapy in lung cancer patientsROCHE SEQUENCING SOLUTIONS INC·Filed 2017·Application pending·0 cites
- 2833US8737698B2Circumferential contact-less line scanning of biometric objectsMIL SHTEIN SAMSON·Filed 2007·Granted May 27, 2014·0 cites·14 claims
- 2933US2011166030A1Prediction of response to docetaxel therapy based on the presence of TMPRSSG2:ERG fusion in circulating tumor cellsWANG YIXIN·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →